SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-031107
Filing Date
2019-06-17
Accepted
2019-06-17 09:23:16
Documents
6
Period of Report
2019-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv523663_8k.htm 8-K 23397
2 EXHIBIT 10.1 tv523663_ex10-1.htm EX-10.1 382013
3 EXHIBIT 10.2 tv523663_ex10-2.htm EX-10.2 233591
4 EXHIBIT 10.3 tv523663_ex10-3.htm EX-10.3 12476
5 EXHIBIT 99.1 tv523663_ex99-1.htm EX-99.1 7138
6 GRAPHIC tv523663_ex99-1img01.jpg GRAPHIC 4486
  Complete submission text file 0001144204-19-031107.txt   666220
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 19900595
SIC: 2834 Pharmaceutical Preparations